Non Viral In-Vivo CAR – Engineering with Episomal DNA: The Next Frontier for Off-the-Shelf & Scalable Cell Therapy
3:30 pm - Thursday 26th February 2026
- Creating a third path to in-vivo CAR-T
- Highlight emerging preclinical evidence demonstrating feasibility and efficacy
New Data
